Jump Financial, LLC Karuna Therapeutics, Inc. Transaction History

Jump Financial, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Oct 21, 2024	SELL	$161.01 - $317.85 $327,655 - $646,824	-2,035 Reduced 63.49%	1,170 $370,000
Q4 2023 Feb 07, 2024	SELL	$161.01 - $317.85 $327,655 - $646,824	-2,035 Reduced 63.49%	1,170 $370,000
Q3 2023 Oct 21, 2024	BUY	$164.66 - $218.08 $10,702 - $14,175	65 Added 2.07%	3,205 $541,000
Q3 2023 Nov 07, 2023	BUY	$164.66 - $218.08 $10,702 - $14,175	65 Added 2.07%	3,205 $541,000
Q2 2023 Oct 21, 2024	BUY	$176.32 - $240.22 $553,644 - $754,290	3,140 New	3,140 $680,000
Q2 2023 Aug 07, 2023	BUY	$176.32 - $240.22 $553,644 - $754,290	3,140 New	3,140 $680,000
Q3 2022 Nov 07, 2022	BUY	$123.79 - $277.42 $1.22 Million - $2.74 Million	9,879 New	9,879 $2.22 Million
Q2 2022 Aug 09, 2022	SELL	$93.97 - $143.33 $319,498 - $487,322	-3,400 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$98.9 - $132.37 $336,260 - $450,058	3,400 New	3,400 $431,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.